Thumbnail

Covid-19 complicated by high Venous Thromboembolism (VTE) and bleed risk in critically ill patients.

  • Study reports abnormally high VTE and high bleed risk in critically ill Covid-19 patients and calls for more effective prevention strategies.
  • Clinicians at NHS hospitals are supporting the care of Covid-19 patients with the use of geko™ devices to reduce the risk of blood clots in the most at risk patients.
 Learn more Contact us

Edema increases 10% per day for 1st three days and 24-47% from Day 3-8 and can range from 21-180 days or longer

Edema impairs wound healing, diminishes quadriceps strength, and causes pain

Edema (swelling) and pain are the leading causes for total joint replacement returns to the emergency department

The geko™ device is superior to graduated compression stockings (GCS) (p=0.02), Wainwright et al

The geko™ device is superior to GCS+IPC, over 30% less swelling p=0.001), Sener et al

The geko™ device significantly improves functional status (TUG test, p = 0.004), Wainwright et al

geko™ is a simple to use, battery operated, wearable device with superior blood flow and microcirculation increase compared to IPC

Takes only a few minutes for patients, caregivers, or nurses to apply

Easy to transition from hospital to home and can be worn 24 hours today without interfering with patient mobilization